This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Dexamethasone Sodium Phosphate Injection USP 10 mg/mL
- Starting date:
- April 5, 2013
- Posting date:
- April 23, 2013
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type I
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-26857
Recalled Products
- Dexamethasone Sodium Phosphate Injection USP 10 mg/mL
Reason
The recall is initiated due to the discovery of visible particles contained in some vials of this batch.
Depth of distribution
Wholesalers and pharmacies in Canada.
Affected products
A. Dexamethasone Sodium Phosphate Injection USP 10 mg/mL
DIN, NPN, DIN-HIM
DIN 00874582Dosage form
- Solution
Strength
- 10 mg/mL
Lot or serial number
- CH1607
Companies
- Recalling Firm
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA
- Marketing Authorization Holder
-
Sandoz Canada Inc.
145 Jules-Léger
Boucherville
J4B 7K8
Quebec
CANADA